Cabalquinto, Dieb A.

HRN: 07-03-75  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/03/2025
CEFTRIAXONE 1G (VIAL)
01/03/2025
01/10/2025
IV
2 Grams
OD
TBI; Multiple Abrasions
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft TissueEye, Ear, Nose, Throat, & MouthCentral Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: